Skip to main content
. 2020 Apr 22;323(20):2089–2090. doi: 10.1001/jama.2020.6771

Table 1. Characteristics and Prevalent Symptoms of 202 Patients Positive for SARS-CoV-2.

Characteristics No. of patients Prevalence, % (95% CI)a
Age, median (IQR), y 56 (45-67)
Sex
Men 97 48.0 (41.0-55.1)
Women 105 52.0 (44.9-59.0)
Smoking status
Never 139 68.8 (61.9-75.1)
Ever 63 31.2 (24.9-38.0)
Current alcohol drinking
No 80 39.6 (32.8-46.7)
Yes 122 60.4 (53.3-67.2)
Comorbidity
None 89 44.1 (37.1-51.2)
Any 113 55.9 (48.8-62.9)
Indication for testing
Exposure to confirmed SARS-CoV-2 contact 70 34.7 (28.1-41.7)
Symptomatic presentation 132 65.4 (58.3-71.9)
Symptoms based on the ARTIQb
Fever 113 55.9 (48.8-62.9)
Dry cough or coughing up mucus 122 60.4 (53.3-67.2)
Blocked nose 73 36.1 (29.5-43.1)
Problems breathing 83 41.1 (34.2-48.2)
Headache 86 42.6 (35.7-49.7)
Sore throat 63 31.2 (24.9-38.1)
Muscle or joint pains 90 44.6 (37.6-51.7)
Chest pain 33 16.3 (11.5-22.2)
Sinonasal pain 35 17.3 (12.4-23.3)
Loss of appetite 110 54.5 ( 47.3-61.5)
Tiredness 138 68.3 (61.4-74.7)
Diarrhea 88 43.6 (36.6-50.7)
Nausea 40 19.8 (14.5-26.0)
Vomiting 13 6.4 (3.5-10.8)
Abdominal pain 25 12.4 (8.2-17.7)
Dizziness 28 13.9 (9.4-19.4)

Abbreviations: ARTIQ, Acute Respiratory Tract Infection Questionnaire; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

a

95% CIs were calculated using Clopper-Pearson method.

b

Patients were asked, “During the 2 weeks preceding the swab administration of the questionnaire, did you experience any of the following symptoms?” (Prevalence is combined responses of “a little” or “a lot.”)